Indian healthtech companies with US operations must satisfy HIPAA 60-day breach timelines and DPDPA 72-hour notification simultaneously — with divergent consent frameworks, BAA structures, and cross-border PHI flow rules that do not map to each other.
Why HIPAA compliance does not transfer to DPDPA
Indian healthtech companies operating across India and the US face a compliance geometry problem that most legal and compliance teams have not fully resolved: HIPAA and DPDPA agree on the principle that patient data must be protected — but they diverge sharply on how consent, breach notification, cross-border transfer, and processor accountability must operate in practice.
Satisfying one framework is difficult. Operating both simultaneously, with one product architecture and one data infrastructure, requires explicit design decisions — not a hope that HIPAA compliance will carry over.
Lawful basis — TPO vs consent-first
HIPAA operates on a Treatment-Payment-Operations (TPO) model — processing for defined healthcare purposes does not always require explicit patient consent. DPDPA defaults to consent as the primary lawful basis for Data Fiduciaries.
An Indian healthtech company handling PHI for Indian patients under DPDPA cannot default to TPO-style processing without patient consent — even if the same data flows under HIPAA are covered by the TPO exemption on the US side. The two populations require different consent architectures.
Breach notification — two timelines, one incident
HIPAA requires notification to individuals within 60 days of a breach discovery; HHS notification follows a separate timeline for large breaches. DPDPA, under draft rules, contemplates a 72-hour notification window to the Data Protection Board.
A single breach affecting both US and Indian patient records triggers both notification obligations simultaneously — with different content requirements, different notification bodies, and different individual disclosure thresholds.
BAA vs DPA — different obligations
US partners require HIPAA Business Associate Agreements (BAAs). Indian processors and cloud platforms require DPDPA-compliant Data Processing Agreements (DPAs). The obligations in each are not identical — the BAA focuses on permitted uses and breach notification; the DPA under DPDPA must address consent basis, withdrawal propagation, and data principal rights.
Many Indian healthtech companies have BAAs with US partners and nothing equivalent with Indian cloud and analytics vendors. This is an inverted risk profile — the stricter obligations exist on the Indian side, where documentation is weakest.
Cross-border PHI flows — the India-US corridor
Sharing Indian patient data with a US partner for clinical processing triggers DPDPA cross-border transfer obligations and HIPAA's requirements for appropriate safeguards when PHI moves outside the covered entity's control. Most Indian healthtech platforms have neither a DPDPA cross-border data flow map nor a formal HIPAA safeguard analysis for the India-US corridor — they have a cloud vendor agreement.
Data subject rights with no HIPAA equivalent
HIPAA grants patients a right to access and amend their records. DPDPA adds withdrawal, nomination, and grievance rights that have no direct HIPAA equivalent — and must be operationalised separately for the Indian patient base. A HIPAA patient portal is not a DPDPA-compliant data principal rights interface.
How Consentica and Privault address dual compliance
Consentica by OpenBlockAI manages separate consent profiles for Indian and US patient interactions — Indian patients receive DPDPA-compliant purpose-specific consent; US interactions are configured to align with HIPAA-permitted processing without requiring consent where TPO exemptions apply.
Privault by OpenBlockAI tokenises PHI before it moves across the India-US boundary — US partner systems receive governed tokens, not raw patient identifiers. Token resolution for US-side clinical processing is policy-bound and logged, satisfying both HIPAA audit requirements and DPDPA cross-border accountability.
Indian healthtech companies that resolve this compliance geometry proactively will close US hospital and health system enterprise deals faster — HIPAA BAA review committees increasingly ask about Indian data handling practices as part of vendor security assessments.